Tisch MS News

Like many of you,  weare also very excited by the Chan Zuckerberg Initiative announcement. Here’s what we know so far:
Tisch MSRCNY is excited to announce that as of September 14, 2016, all 20 patients in our FDA approved Phase I stem cell clinical trial have received their final treatment! Results will be analyzed and presented at our annual patient symposium on October 16th, 2016 at the New York Hilton Midtown. We will submit for publication in leading scientific journals in the near future!
At the heart of the stem cell community is the ISSCR Annual Meeting - a place where breakthrough science, global collaboration, and researchers across the breath of the field come together. The ISSCR Annual Meeting offers the best opportunity to collaborate with leaders and peers from around the world to fully realize the promise of our field in therapies, treatments, and clinical advances. Dr. Violaine Harris (pictured) and Dr. Saud A. Sadiq from Tisch MSRCNY presented their work June 22nd - 25th at this important conference.
Do you walk, jog, swim, dance, run etc.? Are you an iron woman or iron man? Join Team Tisch MS and support the Center! Create an account with Everyday Hero at: http://everydayhero.com/us. For more information send us an email at development@tischms.org.
Saud A. Sadiq, MD, FAAN is the Director and Chief Research Scientist of the Tisch MS Research Center of New York. Dr. Sadiq is a board-certified neurologist with residency training in Internal Medicine in England, and in Neurology at the University of Texas, where he was elected to the Alpha Omega Alpha Honor Medical Society. From 1988-91, he trained as a research fellow funded by a Dana Fellowship award and an MDA Fellowship in Neuroimmunology at Columbia University in New York.
Tisch Multiple Sclerosis Research Center of New York is pleased to share Dr. Saud A. Sadiq's slides presented at the American Academy of Neurology's (AAN) 68TH Annual Meeting in Vancouver, Canada. Neurologists from all over the world gathered to hear the exciting data presented on the Center's FDA- approved stem cell clinical trial for MS. Blitz Presentation.pdf
For Immediate Release:              MS Patients Take Steps without Cane as Damage is Repaired


Subscribe to MSRCNY News